| William Shaffer, MD | |
|
7920 Old Cedar Ave S, Bloomington, MN 55425-1207 | |
| (952) 428-1800 | |
| Not Available |
| Full Name | William Shaffer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 7920 Old Cedar Ave S, Bloomington, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073548459 | NPI | - | NPPES |
| 913585300 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 30779 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allina Health Home Health | Saint paul, MN | Home health agency |
| Home Health Care Inc | Golden valley, MN | Home health agency |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
Allscripts-Misys Healthcare Solutions, Inc., the leading provider of clinical software, information and connectivity solutions for physicians, today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder.
The fate of mature T lymphocytes might be a lot more flexible than previously thought. New research from the RIKEN Center for Allergy and Immunology (RCAI) in Japan and La Jolla Institute for Allergy and Immunology (LIAI) in the USA shows for the first time that mature CD4+ helper T lymphocytes can be re-programed to become killer-like CD8+ T lymphocytes and gain killing functions.
Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.
A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream. In addition to having implications for those who need GH, this first pediatric study of administering it through the lungs may also help researchers interested in using this convenient method for effectively delivering other types of medications to children.
METTLER TOLEDO has announced an online seminar focusing on an industrial perspective of successful techniques to develop a scalable crystallization process – Crystallization Scale-up: An Industry Perspective.
› Verified 2 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Allscripts-Misys Healthcare Solutions, Inc., the leading provider of clinical software, information and connectivity solutions for physicians, today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder.
The fate of mature T lymphocytes might be a lot more flexible than previously thought. New research from the RIKEN Center for Allergy and Immunology (RCAI) in Japan and La Jolla Institute for Allergy and Immunology (LIAI) in the USA shows for the first time that mature CD4+ helper T lymphocytes can be re-programed to become killer-like CD8+ T lymphocytes and gain killing functions.
Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.
A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream. In addition to having implications for those who need GH, this first pediatric study of administering it through the lungs may also help researchers interested in using this convenient method for effectively delivering other types of medications to children.
METTLER TOLEDO has announced an online seminar focusing on an industrial perspective of successful techniques to develop a scalable crystallization process – Crystallization Scale-up: An Industry Perspective.
› Verified 2 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
Allscripts-Misys Healthcare Solutions, Inc., the leading provider of clinical software, information and connectivity solutions for physicians, today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder.
The fate of mature T lymphocytes might be a lot more flexible than previously thought. New research from the RIKEN Center for Allergy and Immunology (RCAI) in Japan and La Jolla Institute for Allergy and Immunology (LIAI) in the USA shows for the first time that mature CD4+ helper T lymphocytes can be re-programed to become killer-like CD8+ T lymphocytes and gain killing functions.
Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.
A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream. In addition to having implications for those who need GH, this first pediatric study of administering it through the lungs may also help researchers interested in using this convenient method for effectively delivering other types of medications to children.
METTLER TOLEDO has announced an online seminar focusing on an industrial perspective of successful techniques to develop a scalable crystallization process – Crystallization Scale-up: An Industry Perspective.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Shaffer, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | William Shaffer, MD 7920 Old Cedar Ave S, Bloomington, MN 55425-1207 Ph: (952) 428-1800 |
News Archive
Allscripts-Misys Healthcare Solutions, Inc., the leading provider of clinical software, information and connectivity solutions for physicians, today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder.
The fate of mature T lymphocytes might be a lot more flexible than previously thought. New research from the RIKEN Center for Allergy and Immunology (RCAI) in Japan and La Jolla Institute for Allergy and Immunology (LIAI) in the USA shows for the first time that mature CD4+ helper T lymphocytes can be re-programed to become killer-like CD8+ T lymphocytes and gain killing functions.
Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.
A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream. In addition to having implications for those who need GH, this first pediatric study of administering it through the lungs may also help researchers interested in using this convenient method for effectively delivering other types of medications to children.
METTLER TOLEDO has announced an online seminar focusing on an industrial perspective of successful techniques to develop a scalable crystallization process – Crystallization Scale-up: An Industry Perspective.
› Verified 2 days ago
Constance Crane, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-851-1000 | |
Jerome C Siy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8170 33rd Ave S, Mc21110q, Bloomington, MN 55425 Phone: 651-254-9594 Fax: 651-254-3662 | |
Christofer A. Smith, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W 98th St, Bloomington, MN 55420 Phone: 952-885-6060 | |
Donald L Zogg, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5705 W Old Shakopee Rd, Bloomington, MN 55437 Phone: 612-871-1145 | |
Randy Kimpell, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-851-1000 | |
Jonathan D. Katz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 W 98th St, Bloomington, MN 55420 Phone: 952-885-6060 |